Path ID: DB11988_MESH_D020528_1

db11988-mesh-d020528-1

Concepts

Identifier Name Type
MESH:C533411 Ocrelizumab Drug
UniProt:P11836 B-lymphocyte antigen CD20 Protein
CL:0000236 B cell Cell
MESH:D020528 Primary progressive multiple sclerosis Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Ocrelizumab NEGATIVELY REGULATES B-Lymphocyte Antigen Cd20
B-Lymphocyte Antigen Cd20 EXPRESSED IN B Cell
B Cell CONTRIBUTES TO Primary Progressive Multiple Sclerosis

Reference: